US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Bladder Cancer market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Bladder Cancer market." Bladder cancer is known to be a urologic malignancy that occurs in the tissues of the urinary bladder. It is generally characterized by the uncontrolled division of cells arising from the epithelial lining and may proliferate to the muscular wall of the urinary bladder. The exact causes of bladder cancer are still unknown. The global Bladder Cancer market is valued at 460 million US$ in 2018 is expected to reach 1140 million US$ by the end of 2025, growing at a CAGR of 12.1% during 2019-2025. This report focuses on Bladder Cancer volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bladder Cancer market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Bristol-Myers Squibb Eli Lilly F. Hoffman-La Roche Pfizer Accord Healthcare AstraZeneca Bedford Lab Merck Sanofi Segment by Regions North America Europe China Japan Segment by Type Intravesical therapy Chemotherapy Preservation therapy Segment by Application Hospital Clinic
Table of Contents Executive Summary 1 Bladder Cancer Market Overview 1.1 Product Overview and Scope of Bladder Cancer 1.2 Bladder Cancer Segment by Type 1.2.1 Global Bladder Cancer Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Intravesical therapy 1.2.3 Chemotherapy 1.2.4 Preservation therapy 1.3 Bladder Cancer Segment by Application 1.3.1 Bladder Cancer Consumption Comparison by Application (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.4 Global Bladder Cancer Market by Region 1.4.1 Global Bladder Cancer Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Bladder Cancer Market Size 1.5.1 Global Bladder Cancer Revenue (2014-2025) 1.5.2 Global Bladder Cancer Production (2014-2025) 2 Global Bladder Cancer Market Competition by Manufacturers 2.1 Global Bladder Cancer Production Market Share by Manufacturers (2014-2019) 2.2 Global Bladder Cancer Revenue Share by Manufacturers (2014-2019) 2.3 Global Bladder Cancer Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Bladder Cancer Production Sites, Area Served, Product Types 2.5 Bladder Cancer Market Competitive Situation and Trends 2.5.1 Bladder Cancer Market Concentration Rate 2.5.2 Bladder Cancer Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Bladder Cancer Production Market Share by Regions 3.1 Global Bladder Cancer Production Market Share by Regions 3.2 Global Bladder Cancer Revenue Market Share by Regions (2014-2019) 3.3 Global Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Bladder Cancer Production 3.4.1 North America Bladder Cancer Production Growth Rate (2014-2019) 3.4.2 North America Bladder Cancer Production, Revenue, Price and Gross Margin (2014-2019) 3.5 Europe Bladder Cancer Production 3.5.1 Europe Bladder ... | read more...